Review highlights exosomal microRNAs aiding early cancer detection and therapeutic monitoring, pointing to challenges in standardization and clinical validation.
Key Points
Exosomal microRNAs improve early cancer detection and prognosis, with significant implications for therapeutic monitoring.
Biomarker discovery based on liquid biopsies has identified key roles of miRNAs in cancer progression and metastasis.
Technological advancements in exosome isolation and profiling are essential to harness the potential of exosomal miRNAs.
Standardization and variability in miRNA expression across cancer types remain challenges for their clinical application.